Dose-related depressive symptoms and suicidal ideation during cabergoline therapy in an adolescent with macroprolactinoma.

Malik S, Al Harrasi A, Al Kiyumi MI, Al Kiyumi MH

Open source

DOI
10.1210/jcemcr/luag351
Published
2026 Dec
Container
JCEM case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1210/jcemcr/luag351,
  title = {Dose-related depressive symptoms and suicidal ideation during cabergoline therapy in an adolescent with macroprolactinoma.},
  author = {Malik S and Al Harrasi A and Al Kiyumi MI and Al Kiyumi MH},
  year = {2026},
  journal = {JCEM case reports},
  doi = {10.1210/jcemcr/luag351},
  url = {https://doi.org/10.1210/jcemcr/luag351}
}

RIS

TY  - JOUR
TI  - Dose-related depressive symptoms and suicidal ideation during cabergoline therapy in an adolescent with macroprolactinoma.
AU  - Malik S
AU  - Al Harrasi A
AU  - Al Kiyumi MI
AU  - Al Kiyumi MH
PY  - 2026
JO  - JCEM case reports
DO  - 10.1210/jcemcr/luag351
UR  - https://doi.org/10.1210/jcemcr/luag351
ER  - 

APA

S, M., A, A. H., MI, A. K., & MH, A. K. (2026). Dose-related depressive symptoms and suicidal ideation during cabergoline therapy in an adolescent with macroprolactinoma.. JCEM case reports. https://doi.org/10.1210/jcemcr/luag351

Source records